GLAUKOS Corp Research and Development Expense
GLAUKOS Corp (GKOS) reported Research and Development Expense of $26.88 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2022-05-05
- GLAUKOS Corp research and development expense for the quarter ending 2022-03-31 was $26.88M, a 26.66% increase year-over-year.
- GLAUKOS Corp research and development expense for the quarter ending 2021-03-31 was $21.22M.
- GLAUKOS Corp research and development expense for the quarter ending 2019-03-31 was $13.93M, a 27.73% increase year-over-year.
- GLAUKOS Corp research and development expense for the quarter ending 2018-12-31 was $12.96M, a 23.11% increase year-over-year.
- GLAUKOS Corp research and development expense for fiscal 2018 was $49.68M, a 27.69% increase from fiscal 2017.
- GLAUKOS Corp research and development expense for fiscal 2017 was $38.91M, a 33.13% increase from fiscal 2016.
- GLAUKOS Corp research and development expense for fiscal 2016 was $29.22M, a 16.67% increase from fiscal 2015.
- GLAUKOS Corp research and development expense for fiscal 2015 was $25.05M, a 30.42% increase from fiscal 2014.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2022-03-31 | $26.88M 10-Q · filed 2022-05-05 | |||
| 2021-03-31 | $21.22M 10-Q · filed 2022-05-05 | |||
| 2019-03-31 | $13.93M 10-Q · filed 2019-05-08 | $26.89M derived: sum of 2 quarters · filed 2019-05-08 | $40.09M derived: sum of 3 quarters · filed 2019-05-08 | $52.70M derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-12-31 | $12.96M 10-K · filed 2019-02-28 | $26.16M derived: sum of 2 quarters · filed 2019-02-28 | $38.77M derived: sum of 3 quarters · filed 2019-02-28 | $49.68M 10-K · filed 2019-02-28 |
| 2018-09-30 | $13.20M 10-K · filed 2019-02-28 | $25.81M derived: sum of 2 quarters · filed 2019-02-28 | $36.72M derived: sum of 3 quarters · filed 2019-05-08 | $47.24M derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-06-30 | $12.61M 10-K · filed 2019-02-28 | $23.52M derived: sum of 2 quarters · filed 2019-05-08 | $34.04M derived: sum of 3 quarters · filed 2019-05-08 | $43.85M derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-03-31 | $10.91M 10-Q · filed 2019-05-08 | $21.43M derived: sum of 2 quarters · filed 2019-05-08 | $31.24M derived: sum of 3 quarters · filed 2019-05-08 | $40.87M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $10.53M 10-K · filed 2019-02-28 | $20.33M derived: sum of 2 quarters · filed 2019-02-28 | $29.96M derived: sum of 3 quarters · filed 2019-02-28 | $38.91M 10-K · filed 2019-02-28 |
| 2017-09-30 | $9.80M 10-K · filed 2019-02-28 | $19.44M derived: sum of 2 quarters · filed 2019-02-28 | $28.38M derived: sum of 3 quarters · filed 2019-02-28 | $35.78M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $9.63M 10-K · filed 2019-02-28 | $18.57M derived: sum of 2 quarters · filed 2019-02-28 | $25.97M derived: sum of 3 quarters · filed 2019-02-28 | $33.78M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $8.94M 10-K · filed 2019-02-28 | $16.34M derived: sum of 2 quarters · filed 2019-02-28 | $24.15M derived: sum of 3 quarters · filed 2019-02-28 | $31.10M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $7.40M 10-K · filed 2018-02-28 | $15.21M derived: sum of 2 quarters · filed 2018-02-28 | $22.16M derived: sum of 3 quarters · filed 2018-02-28 | $29.22M 10-K · filed 2019-02-28 |
| 2016-09-30 | $7.81M 10-K · filed 2018-02-28 | $14.76M derived: sum of 2 quarters · filed 2018-02-28 | $21.82M 10-Q · filed 2016-11-14 | $28.12M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $6.96M 10-K · filed 2018-02-28 | $14.02M 10-Q · filed 2016-08-04 | $20.31M derived: sum of 3 quarters · filed 2018-02-28 | $26.48M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $7.06M 10-K · filed 2018-02-28 | $13.36M derived: sum of 2 quarters · filed 2018-02-28 | $19.53M derived: sum of 3 quarters · filed 2018-02-28 | $26.87M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $6.29M 10-K · filed 2017-03-15 | $12.47M derived: sum of 2 quarters · filed 2017-03-15 | $19.81M derived: sum of 3 quarters · filed 2017-03-15 | $25.05M 10-K · filed 2018-02-28 |
| 2015-09-30 | $6.17M 10-K · filed 2017-03-15 | $13.51M derived: sum of 2 quarters · filed 2017-03-15 | $18.75M 10-Q · filed 2016-11-14 | $24.06M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $7.34M 10-K · filed 2017-03-15 | $12.58M 10-Q · filed 2016-08-04 | $17.89M derived: sum of 3 quarters · filed 2017-03-15 | $22.98M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $5.24M 10-K · filed 2017-03-15 | $10.55M derived: sum of 2 quarters · filed 2017-03-15 | $15.64M derived: sum of 3 quarters · filed 2017-03-15 | $20.06M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $5.31M 10-K · filed 2016-03-15 | $10.40M derived: sum of 2 quarters · filed 2016-03-15 | $14.82M derived: sum of 3 quarters · filed 2016-03-15 | $19.20M 10-K · filed 2017-03-15 |
| 2014-09-30 | $5.09M 10-K · filed 2016-03-15 | $9.52M derived: sum of 2 quarters · filed 2016-03-15 | $13.90M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $4.42M 10-K · filed 2016-03-15 | $8.80M 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | $4.38M 10-K · filed 2016-03-15 | |||
| 2013-12-31 | $15.51M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |